TH77926A - Anthra nilamide New pyridin urea as a receptor kinase inhibitor of vascular endothelium proliferation (VEGF). - Google Patents
Anthra nilamide New pyridin urea as a receptor kinase inhibitor of vascular endothelium proliferation (VEGF).Info
- Publication number
- TH77926A TH77926A TH501005129A TH0501005129A TH77926A TH 77926 A TH77926 A TH 77926A TH 501005129 A TH501005129 A TH 501005129A TH 0501005129 A TH0501005129 A TH 0501005129A TH 77926 A TH77926 A TH 77926A
- Authority
- TH
- Thailand
- Prior art keywords
- nilamide
- anthra
- urea
- kinase inhibitor
- vegf
- Prior art date
Links
- PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical compound NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 title abstract 6
- 229940043355 kinase inhibitor Drugs 0.000 title abstract 3
- 239000003757 phosphotransferase inhibitor Substances 0.000 title abstract 3
- GAOJUAYPDKVFDO-UHFFFAOYSA-N pyridine;urea Chemical compound NC(N)=O.C1=CC=NC=C1 GAOJUAYPDKVFDO-UHFFFAOYSA-N 0.000 title abstract 3
- 108091005682 Receptor kinases Proteins 0.000 title 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 title 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 title 1
- 210000003989 endothelium vascular Anatomy 0.000 title 1
- 230000035755 proliferation Effects 0.000 title 1
- 239000000126 substance Substances 0.000 claims abstract 3
- 229940079593 drug Drugs 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 229910052731 fluorine Chemical group 0.000 claims 1
- 239000011737 fluorine Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 108091008605 VEGF receptors Proteins 0.000 abstract 2
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 abstract 2
- 210000004204 blood vessel Anatomy 0.000 abstract 2
- 229940126585 therapeutic drug Drugs 0.000 abstract 2
Abstract
DC60 (30/01/49) การประดิษฐ์นี้เกี่ยวข้องกับ แอนธรานิลาไมด์ ไพริดินยูเรีย ชนิดใหม่ที่เป็นสารยับยั้งไคเนส ของรีเซพเตอร์ VEGF, การผลิตสารเหล่านี้และการใช้เป็นยาสำหรับการบำบัดโรคซึ่งกระตุ้นโดยการ สร้างหลอดเลือดใหม่ที่เกิดขึ้นต่อเนื่องไป การประดิษฐ์นี้เกี่ยวข้องกับ แอนธรานิลาไมด์ ไพริดินยูเรีย ชนิดใหม่ที่เป็นสารยับยั้งไคเนส ของรีเซพเตอร์ VEGF, การผลิตสารเหล่านี้และการใช้เป็นยาสำหรับการบำบัดโรคซึ่งกระตุ้นโดยการ สร้างหลอดเลือดใหม่ที่เกิดขึ้นต่อเนื่องไป สิทธิบัตรยา DC60 (30/01/49) This invention relates to Anthra nilamide Pyridin urea A new type of kinase inhibitor Of VEGF receptors, the production of these substances and their use as a therapeutic drug stimulated by To create new blood vessels that occur continuously This invention involves Anthra nilamide Pyridin urea A new type of kinase inhibitor Of VEGF receptors, the production of these substances and their use as a therapeutic drug stimulated by It creates new blood vessels that continue to patent the drug.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH77926A true TH77926A (en) | 2006-06-05 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20065946L (en) | DPP-IV inhibitors | |
| CR9078A (en) | DERIVED FROM BENCIMIDAZOL ARILOXI-SUBSTITUTES | |
| ATE551059T1 (en) | FASUDIL IN COMBINATION WITH BOSENTAN FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION | |
| CR8744A (en) | THERAPEUTIC COMPOUNDS | |
| EA200700168A1 (en) | DERIVATIVES OF THE SUBSTITUTED CYCLIC UREA, THEIR OBTAINING AND THEIR PHARMACEUTICAL APPLICATION AS KINASE INHIBITORS | |
| DK1716152T3 (en) | Condensed heterocyclic compounds and their use as metabotropic receptor antagonists in the treatment of gastrointestinal disorders | |
| CY1108252T1 (en) | USE OF Methylene Amide Derivatives in Cardiovascular Disorders | |
| SG153811A1 (en) | Quinazolinone derivatives useful as vanilloid antagonists | |
| ATE418548T1 (en) | SUBSTITUTED 3-CYANOTHIOPHENE ACETAMIDE AS GLUCAGON RECEPTOR ANTAGONISTS | |
| ECSP066883A (en) | USEFUL HETEROARILAMINOPIRAZOL DERIVATIVES FOR THE TREATMENT OF DIABETES | |
| ATE432260T1 (en) | PYRIDINE DERIVATIVES AS PKC-THETA INHIBITORS | |
| ATE413392T1 (en) | CONDENSED HETEROYRAL DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS | |
| WO2007065662A3 (en) | Trisubstituted quinazolinone derivatives as vanilloid antagonists | |
| WO2007120333A3 (en) | Tetracyclic kinase inhibitors | |
| EA200602281A1 (en) | Heteroarylsulphones and Sulfonamides and Their Therapeutic Applications | |
| TH77926A (en) | Anthra nilamide New pyridin urea as a receptor kinase inhibitor of vascular endothelium proliferation (VEGF). | |
| BRPI0615141A2 (en) | pentacyclic kinase inhibitors | |
| CL2004001507A1 (en) | COMPOUNDS DERIVED FROM SUBSTITUTED ESPIROBENZOBENZAZEPINAS, VASOPRESINE RECEIVER INHIBITORS; PHARMACEUTICAL COMPOSITION; USEFUL IN THE TREATMENT OF HYPERTENSION, CARDIAC DYSFUNCTION, RENAL INSUFFICIENCY, AMONG OTHERS. | |
| WO2008098077A3 (en) | Substituted alkine derivatives as anti-cancer agents | |
| NO20081529L (en) | naphthyridine | |
| PA8576701A1 (en) | QUINAZOLINE DERIVATIVES | |
| ITRM20050090A1 (en) | DERIVATIVES OF AMINO-BUTANOIC ACID INHIBITOR OF THE CPT. | |
| ATE455095T1 (en) | VANILLOID RECEPTOR TRPV1 ANTAGONISTS | |
| ATE531698T1 (en) | 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUNDS WITH ANTIVIRAL EFFECT | |
| DOP2009000145A (en) | DERIVATIVES OF 8-ETINYLXANTINE AS SELECTIVE A2A RECEIVER ANTAGONISTS |